Intellectual Property India Publishes Patent Application for 'Use Of Long-Acting Fluticasone Propionate Injectable Suspensions For Treating And Preventing Inflammations Of The Gastrointestinal Tract' Filed by Eupraxia Pharmaceuticals Inc.

MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517042891 A) filed by Eupraxia Pharmaceuticals Inc., Victoria, Canada, on May 2, for 'use of long-acting fluticasone propionate injectable suspensions for treating and preventing inflammations of the gastrointestinal tract.'

Inventor(s) include Helliwell, James; Malone, Amanda; Webb, Murray; Price, James; Loss, Troy; Price, Nicola; and Brennan, Paul.

The application for the patent was published on June 13, under issue no. 24/2025.

According to the abstract released by the Intellectual Property India: "Disclosed herein are methods for treating or preventing inflammatory diseases of the gastrointestinal (GI) tract by locally administering a pharmac...